Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
29M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
2.04M
-
Shares change
-
+1.61M
-
Total reported value, excl. options
-
$2.22M
-
Value change
-
+$1.75M
-
Number of buys
-
7
-
Number of sells
-
-6
-
Price
-
$1.09
Significant Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q3 2024
20 filings reported holding ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share as of Q3 2024.
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.04M shares
of 29M outstanding shares and own 7.05% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.34M shares), New Leaf Venture Partners, L.L.C. (345K shares), Apollon Financial, LLC (225K shares), Alpine Global Management, LLC (64.8K shares), XTX Topco Ltd (33K shares), TWO SIGMA SECURITIES, LLC (14.9K shares), GEODE CAPITAL MANAGEMENT, LLC (12.4K shares), MORGAN STANLEY (5.48K shares), Activest Wealth Management (133 shares), and WELLS FARGO & COMPANY/MN (85 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.